Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment

Julius Kieswich, Sophie R. Sayers, Marta F. Silvestre, Steven M. Harwood, Muhammad M. Yaqoob, Paul W. Caton

Open source

DOI
10.1007/s00125-016-4076-3
Published
2016-08-19
Container
Diabetologia
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00125-016-4076-3,
  title = {Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment},
  author = {Julius Kieswich and Sophie R. Sayers and Marta F. Silvestre and Steven M. Harwood and Muhammad M. Yaqoob and Paul W. Caton},
  year = {2016},
  journal = {Diabetologia},
  doi = {10.1007/s00125-016-4076-3},
  url = {https://doi.org/10.1007/s00125-016-4076-3}
}

RIS

TY  - JOUR
TI  - Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment
AU  - Julius Kieswich
AU  - Sophie R. Sayers
AU  - Marta F. Silvestre
AU  - Steven M. Harwood
AU  - Muhammad M. Yaqoob
AU  - Paul W. Caton
PY  - 2016
JO  - Diabetologia
DO  - 10.1007/s00125-016-4076-3
UR  - https://doi.org/10.1007/s00125-016-4076-3
ER  - 

APA

Kieswich, J., Sayers, S. R., Silvestre, M. F., Harwood, S. M., Yaqoob, M. M., & Caton, P. W. (2016). Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment. Diabetologia. https://doi.org/10.1007/s00125-016-4076-3

Source records